Pharmaceutical Investing EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437
G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights
Fortune Minerals Reports Successful NICO Project Bismuth Test Work Results for the Planned Alberta Refinery